Seguimiento de la tromboembolia pulmonar

Uresandi, Fernando; Iruin, Gemma; Gómez, Beatriz; Uresandi, Amaia.
Med. clín (Ed. impr.) ; 131(supl.2): 54-59, nov. 2008. ilus, tab
Artículo en Es | IBECS (España) | ID: ibc-71390

Documentos relacionados

  1. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism.
  2. Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study.
  3. [Consolidate the foundation, steadily promote and comprehensively improve the quality control in prevention and management of venous thromboembolism in China].
  4. [Successful treatment of high-risk pulmonary embolism with low-dose anticoagulation: a case report].
  5. Clinical characteristics and 3-month outcomes in cancer patients with incidental <i>versus</i> clinically suspected and confirmed pulmonary embolism.
  6. The Vienna Prediction Model for identifying patients at low risk of recurrent venous thromboembolism: a prospective cohort study.
  7. An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug.
  8. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
  9. Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience.
  10. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism.